Chamber and committees

There are a wide range of definitions for Stroke Units and it is understandable that stroke units will look very different between, for instance, a large city hospital and island NHS Boards

The core criteria for defining a stroke unit are well described in the academic literature, including in Langhorne et al (2002). Professor Langhorne is a member of the Scottish Stroke Care Audit (SSCA) Team and has been influential in defining different models of stroke unit care.

NHS Boards are expected to describe their stroke unit models through the SSCA processes and the Scottish Stroke Improvement Programme Team review this information during Board Reviews (now occurring at least twice annually). This ensures that optimal and evidence based services are being delivered and demonstrates that stroke units are viewed as a core component of care.

I refer the member to the answer to question S6W-05487 on 21 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

There is evidence that access to a stroke unit improves outcome for stroke patients.

The Scottish Stroke Care Audit (SSCA) monitors the quality of care provided by the hospitals in all NHS Boards and access to a stroke unit is a standard measured by SSCA, alongside other standards associated with improved patient outcomes. Performance against the standards, and more detail on service models can be found here:

Scottish stroke improvement programme 2021 national report - Scottish stroke improvement programme - Publications - Public Health Scotland .

Planning of community rehabilitation delivery is the responsibility of individual NHS Boards and Health and Social Care Partnerships.

Our vision is for everyone with rehabilitation needs to be able to access the care and support they need to live well, on their own terms. Exploring ways to improve access to rehabilitation is a key aspect of the work underway to develop a progressive stroke pathway document.

With regard to measuring performance, the provision of appropriate rehabilitation, in both acute and community settings, currently forms part of the Scottish Stroke Improvement Programme (SSIP) criteria-based assessments.

These are currently being reviewed and expanded and will form part of the regular reviews which are undertaken by the Scottish Stroke Improvement Programme team with each Health and Social Care Partnership. We will also consider how these might be integrated into the Scottish Stroke Care Audit if effective.

The Government is clear that the intended purpose of the revised payment arrangements from April 2022 is to recover NHS dental services to ensure that NHS dental contractors can provide necessary care to patients.

NHS dental contractors will therefore receive a multiplier payment in addition to the value of their actual item of service claims. This is part of a blended system of payments which also includes allowance payments, capitation and continuing care and direct reimbursement of expenses such as rental costs. The multiplier arrangement is a fair and equitable response to the current situation of restrictions facing dentistry by returning discretion of earnings back to independent NHS dental contractors.

Every three months the value of the multiplier will be set against concurrent infection, prevention and control restrictions, levels of dental activity and other budgetary considerations at the time of the review point. The purpose of these revised arrangements is to continue to provide appropriate financial support to NHS dental contractors and is therefore assisting in ongoing business planning.

This information is not held centrally.

The Scottish Government is committed to ensuring that all people living in Scotland who want to work, including those receiving adult social care support, are able to access appropriate and flexible employability support.

We will continue to work towards our ambition to reduce the disability employment gap by at least half by 2038 as set out in the Fairer Scotland for Disabled People: Employment Action Plan. We will do this by supporting disabled people into employment , and ensuring that employers have the skills they need to recruit and retain this vastly underutilised pool of talent. We have reviewed current approaches to supporting disabled people with additional support needs into employment and will publish the findings by Summer 2022.

Through this plan we will work to ensure that our social care system delivers the right type and mix of support to help remove the barriers to work for disabled people.

Current models of care should afford flexibility to the individual to take up employment where possible subject to individual care needs being met. We are currently reviewing the guidance on Self Directed Support (SDS) to strengthen consistency and choice in the way social care is provided.

Going forward, we are committed to building on this as we work towards establishing a National Care Service to provide high quality, consistent and fair social care support across Scotland that enables people to achieve the outcomes they want to lead a full life.

The Scottish Government is committed to ensuring that all children and young people are able to access the right support for their mental health without stigma, including medication where this is the most appropriate intervention.

The Scottish Government does not hold data on the numbers of children and young people aged 19 and under who were prescribed antidepressants by a GP, without seeing a specialist, while waiting for access to Child and Adolescent Mental Health Services (CAMHS).

We know that the Covid-19 pandemic has been exceptionally difficult for the mental health and wellbeing of many children, young people and their families. Long waiting times for treatment are unacceptable and we remain committed to meet the standard that 90% of patients begin treatment within 18 weeks of referral. This is why in the 2021-22 financial year we have allocated nearly £40 million to NHS Boards to improve CAMHS; with £4.25 million specifically invested this year to help NHS Boards tackle backlogs, with a clear view of meeting standards and clearing CAMHS backlogs by March 2023.

As set out in the response to S6W-07188 on 21 March 2022, prescribing is a clinical decision based on a prescriber’s judgment as to what they believe is in the best interests of the patient. The prescribing of antidepressants for children and young people is undertaken in consultation with the patient, and where appropriate with their family, to ensure that patient choice is also central to decisions taken regarding treatment and care.

Medication is one aspect of treatment, alongside psychological therapy or other therapeutic interventions, available as an option for children and young people who require support. We continue invest and improve access to other services, including by providing £16 million per annum to ensure that every secondary school in Scotland has access to counselling support; and by investing £15 million in community-based mental health and wellbeing services as part of our focus on early intervention and prevention.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government is committed to ensuring that all children and young people are able to access the right support for their mental health without stigma, including medication where this is the most appropriate intervention.

The Scottish Government does not hold data on the numbers of children and young people aged 19 and under who were prescribed antidepressants by a GP, without seeing a specialist.

Prescribing is a clinical decision based on a prescriber’s judgment as to what they believe is in the best interests of the patient. The prescribing of antidepressants to children and young people is undertaken in consultation with the patient and, where appropriate, with their family, to ensure that patient choice is also central to decisions taken regarding treatment and care.

Medication is one aspect of treatment, alongside psychological therapy or other therapeutic interventions, available as an option for children and young people who require support. We continue invest and improve access to other services, including by providing £16 million per annum to ensure that every secondary school in Scotland has access to counselling support; and by investing £15 million in community-based mental health and wellbeing services as part of our focus on early intervention and prevention.

Children and young people who are prescribed antidepressants will receive regular medication reviews with their prescribing clinician. The frequency and structure of these reviews will be based on the clinician’s judgment and on consultation with the patient and, where appropriate, with the patient’s family.

Clinicians will refer to the British National Formularyfor Children (BNFC) when prescribing antidepressant medication to children. The BNFC is the standard UK paediatric reference for prescribing and pharmacology.

Clinicians can also refer to National Institute for Health and Care Excellence (NICE) guideline NG134 which sets out further advice for the prescribing of antidepressant medication to children and young people.